Espirar

Indications

Espirar is a fixed combination of a cooling agent/mild local anesthetic (levomenthol) with three antiseptic/mild-antimicrobial agents (thymol, terpineol, and chlorobutanol), formulated as a gargle, mouthwash, throat spray, or lozenge for topical/oromucosal use.

• Established/labelled use: Symptomatic relief of minor throat irritation, soreness, and scratchiness associated with common cold, dry throat, or mild pharyngitis.
• Established/labelled use: Antisepsis of the mouth and throat, used as an adjunct oral hygiene/gargle measure to help reduce the microbial load of the oral cavity.
• Symptomatic/adjunct use: Temporary relief of the sensation of nasal or upper-respiratory congestion when used as a topical/inhalant preparation, due to the cooling effect of levomenthol.

Espirar is intended only for short-term, symptomatic relief. It is not a substitute for antibiotic therapy when a significant bacterial throat infection (e.g., streptococcal pharyngitis) is suspected; a physician should evaluate persistent, severe, or worsening throat symptoms.

Levomenthol + Thymol + Terpineol + Chlorobutanol combines four active ingredients, each contributing a distinct local effect:

• Levomenthol – a cooling agent that produces a mild local anesthetic and decongestant sensation on mucous membranes.
• Thymol – a phenolic antiseptic derived from thyme oil with mild antimicrobial activity against common oral and throat organisms.
• Terpineol – an antiseptic terpene alcohol with mild expectorant properties.
• Chlorobutanol – a chlorinated agent that acts as a mild local anesthetic and also functions as an antiseptic/preservative within the formulation.

Espirar is a fixed-dose combination antiseptic preparation used topically in the mouth and throat. It is formulated as products such as gargles, mouthwashes, throat sprays, or lozenges intended for symptomatic relief of minor throat discomfort and for mild antisepsis of the oral cavity.

Espirar works locally at the site of application; it is not intended for systemic treatment of infection and is not itself classified as an antibiotic. The combination is typically available as an over-the-counter preparation for short-term, self-limited symptom relief.

Topical/Oromucosal Antiseptic and Local Anesthetic Combination – Espirar (Throat and Mouth Preparation)

Pharmacology

Levomenthol + Thymol + Terpineol + Chlorobutanol acts locally on the mucosa of the mouth and throat through the combined effect of its four components:

• Levomenthol stimulates cold-sensitive (TRPM8) receptors in the mucosa, producing a cooling sensation and mild local anesthetic/counter-irritant effect that is perceived as decongestant and soothing.
• Thymol disrupts the cell membranes of bacteria and fungi, giving it mild broad-spectrum antiseptic activity on mucosal surfaces.
• Terpineol has antiseptic and mild expectorant properties, contributing additional local antimicrobial action and a subjective easing of mucus.
• Chlorobutanol provides local anesthesia by a mild membrane-stabilizing effect on sensory nerve endings and contributes antiseptic/preservative activity within the product.

Systemic absorption from topical/oromucosal use of Levomenthol + Thymol + Terpineol + Chlorobutanol is minimal when used as directed, so its actions are predominantly local rather than systemic.

Espirar is for topical/oromucosal (mouth and throat) use only:

• Gargle/mouthwash: Dilute if required, gargle, and spit out; avoid swallowing the solution.
• Spray: Direct the spray to the back of the throat, avoiding inhalation of excess spray.
• Lozenge: Dissolve slowly in the mouth; do not chew or swallow whole.

Avoid contact with the eyes. Do not use on broken skin or open wounds. Espirar is not intended for injection or for use on the eyes.

Drug Interactions

Because Espirar is applied topically to the mouth and throat with minimal systemic absorption, clinically significant systemic drug interactions are unlikely when it is used as directed. The following points are relevant:

• Concurrent use with other menthol-, camphor-, or phenol-containing topical products (e.g., other throat sprays, chest rubs, or lozenges) may increase local irritation or additive local anesthetic effect; avoid combining multiple menthol/antiseptic products at the same time without medical advice.
• No well-established, clinically significant systemic drug-drug interactions have been documented for Espirar at recommended topical doses.

Side Effects

Espirar is generally well tolerated when used as directed. Reported side effects are usually local and mild:

• Local burning, stinging, or tingling sensation in the mouth or throat.
• Mild throat or oral mucosal irritation.
• Rare hypersensitivity reactions (e.g., rash, itching, or swelling) in sensitive individuals.

Discontinue use and seek medical advice if signs of an allergic reaction or persistent irritation occur.

Pregnancy and Lactation

Data on the use of Espirar during pregnancy and lactation are limited. As with most topical antiseptic/local-anesthetic combinations, Espirar should be used during pregnancy or breastfeeding only if clearly needed and only as directed, avoiding excessive or prolonged use. Pregnant or breastfeeding individuals should consult a physician before use, particularly for repeated or prolonged use, so that potential benefit can be weighed against any potential risk.

Precautions and Warnings

• Espirar is intended for external/topical or short-term oromucosal use only, strictly as directed on the product label.
• Avoid excessive or prolonged use; if symptoms do not improve within a few days or worsen, stop use and consult a physician.
• Avoid contact with the eyes; if accidental eye contact occurs, rinse thoroughly with water.
• Not a substitute for medical treatment of a significant throat infection (e.g., streptococcal pharyngitis), which may require antibiotic evaluation if bacterial in origin.
• Use with caution in young children; follow the minimum age stated on the specific product label because of the risk of laryngospasm with menthol-containing products.
• Avoid swallowing gargle/mouthwash solutions; spit out after use.

Overdose

Accidental ingestion of a large amount of Espirar (particularly the gargle/mouthwash form) may cause nausea, vomiting, abdominal discomfort, or central nervous system effects such as drowsiness or unsteadiness, related mainly to the menthol and chlorobutanol content. If overdose or accidental large-volume ingestion is suspected, seek immediate medical attention or contact a poison control center; do not attempt specific home treatment beyond removing residual product from the mouth and rinsing with water.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Use in Special Populations

• Children: Use only per the minimum age stated on the specific product label; avoid use in infants and young children due to the risk of laryngospasm associated with menthol near the nose and throat. See Contraindications.
• Elderly: No specific dose adjustment is generally required for Espirar in older adults; use as directed.
• Renal or hepatic impairment: Because systemic absorption of Espirar from topical/oromucosal use is minimal, no specific dose adjustment is established for renal or hepatic impairment; use as directed and consult a physician if there are concerns.

Espirar is intended for short-term, symptomatic use, generally not exceeding 5–7 days without medical advice. If throat irritation or discomfort persists beyond this period, worsens, or is accompanied by fever, difficulty swallowing, or breathing difficulty, discontinue use and consult a physician.

Topical Antiseptics; Oromucosal Local Anesthetics

Levomenthol + Thymol + Terpineol + Chlorobutanol acts locally at the mucosal surface: levomenthol stimulates cold-sensitive nerve receptors to produce a cooling, mildly anesthetic and decongestant sensation, while thymol and terpineol exert mild antiseptic (antimicrobial) activity against organisms on the oral and pharyngeal mucosa, and chlorobutanol contributes additional local anesthetic and antiseptic/preservative action. Together these actions provide symptomatic relief of throat irritation and mild antisepsis of the mouth and throat.

Pediatric Use

The safety and efficacy of Espirar in infants and young children have not been established for most formulations, and menthol-containing products are associated with a risk of laryngospasm and reflex apnea in this age group. Espirar should be used in children only at or above the minimum age specified on the individual product label, and under the guidance of a physician or pharmacist. It should not be applied near the nose or mouth of infants.